Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Pietra

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Thrombosis Research|May 3, 2014
Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databasesFrancesco Dentali, Walter Ageno, Elisa Rumi, et al.
Oncotarget|April 20, 2017
Sequential evaluation of CALR mutant burden in patients with myeloproliferative neoplasmsChiara Cavalloni, Elisa Rumi, Virginia V Ferretti, et al.
American Journal of Hematology|October 22, 2013
A novel germline JAK2 mutation in familial myeloproliferative neoplasmsElisa Rumi, Ashot S Harutyunyan, Ilaria Casetti, et al.
Blood|January 12, 2008
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosisFrancesco Passamonti, Elisa Rumi, Marianna Caramella, et al.
Annals of Hematology|July 24, 2015
Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion geneElisa Rumi, Jelena D Milosevic, Dominik Selleslag, et al.
American Journal of Hematology|March 10, 2022
Isolated congenital asplenia: An overlooked cause of thrombocytosisOscar Borsani, Takaki Asano, Bertrand Boisson, et al.
Frontiers in Oncology|September 20, 2021
Enrichment of Double RUNX1 Mutations in Acute Leukemias of Ambiguous LineageGabriele Merati, Marianna Rossi, Anna Gallì, et al.
American Journal of Hematology|April 12, 2019
Ruxolitinib treatment and risk of B-cell lymphomas in myeloproliferative neoplasmsElisa Rumi, Silvia Zibellini, Emanuela Boveri, et al.
Ejhaem|July 18, 2022
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasmsDaniele Vanni, Oscar Borsani, Yasuhito Nannya, et al.
Blood Cancer Journal|December 9, 2017
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profilesRoberta Zini, Paola Guglielmelli, Daniela Pietra, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Thrombosis Research|May 3, 2014
Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databasesFrancesco Dentali, Walter Ageno, Elisa Rumi, et al.
Oncotarget|April 20, 2017
Sequential evaluation of CALR mutant burden in patients with myeloproliferative neoplasmsChiara Cavalloni, Elisa Rumi, Virginia V Ferretti, et al.
American Journal of Hematology|October 22, 2013
A novel germline JAK2 mutation in familial myeloproliferative neoplasmsElisa Rumi, Ashot S Harutyunyan, Ilaria Casetti, et al.
Blood|January 12, 2008
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosisFrancesco Passamonti, Elisa Rumi, Marianna Caramella, et al.
Annals of Hematology|July 24, 2015
Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion geneElisa Rumi, Jelena D Milosevic, Dominik Selleslag, et al.
American Journal of Hematology|March 10, 2022
Isolated congenital asplenia: An overlooked cause of thrombocytosisOscar Borsani, Takaki Asano, Bertrand Boisson, et al.
Frontiers in Oncology|September 20, 2021
Enrichment of Double RUNX1 Mutations in Acute Leukemias of Ambiguous LineageGabriele Merati, Marianna Rossi, Anna Gallì, et al.
American Journal of Hematology|April 12, 2019
Ruxolitinib treatment and risk of B-cell lymphomas in myeloproliferative neoplasmsElisa Rumi, Silvia Zibellini, Emanuela Boveri, et al.
Ejhaem|July 18, 2022
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasmsDaniele Vanni, Oscar Borsani, Yasuhito Nannya, et al.
Blood Cancer Journal|December 9, 2017
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profilesRoberta Zini, Paola Guglielmelli, Daniela Pietra, et al.
Pageof 10